CDC advisors raise concerns about ‘over-vaccination’ and ask the White House for more data to show boosters are needed

CDC advisors raise concerns about ‘over-vaccination’ and ask the White House for more data to show boosters are needed

That, starting on September 20, third doses of Pfizer and Moderna's COVID-19 vaccines should start to become available to Americans who were the first in line to receive their initial two-shot vaccines. But federal experts who are working behind the scenes on vaccine regulation and safety are still clambering for more evidence that those third doses are really needed at this juncture for everyone. "If we're going to move in this direction, I want to see the data," registered nurse Lynn Bahta, who serves on the Centers for Disease Control and Prevention's independent advisory committee on vaccines, said during a meeting earlier this week. The timing of booster shots matters to our collective immunity against COVID-19, and it's not clear yet to many top experts, including those working inside the CDC and FDA, that most people (aside from the elderly or immunocompromised) . On Friday, the that the heads of both the CDC and FDA are now urging the White House to walk back its booster recommendation. Their warnings echo the panel of independent advisors to the CDC, who met earlier this week and raised concerns about rolling out boosters before we have the data for it — risking "over-vaccination."